Abstract:Background: Alcohol relapse is a major problem in the treatment of alcohol abuse and alcoholism. Understanding the long-term neuronal alterations that promote relapse of alcohol drinking is critical for the development of pharmacotherapies to treat alcoholism and alcohol abuse. The major objectives of this workshop were to present recent findings, by using rodent models, on behavioral and neurobiological factors that may underlie alcohol relapse and the results of clinical and pharmacological treatment strategies for preventing relapse. Methods: Prolonged ethanol drinking and repeated periods of alcohol deprivation were studied in nonselected rats and in rats selectively bred for high alcohol preference (P rat). The expression of a robust alcohol deprivation effect (ADE) was used as a model for alcohol relapse in rodents. Operant techniques were used to examine responding for ethanol after deprivation in both rats and C57BL/6J mice. Environmental cues and stress were used to assess their effects on reinstatement of alcohol responding. Microdialysis and [14C]-2-deoxyglucose techniques were used to examine neuronal alterations associated with alcohol relapse. Results: Prolonged free-choice ethanol drinking followed by deprivation produced an ADE in both stock and P rats. These rats demonstrated loss of control on reinstatement after chronic drinking and after prolonged deprivation. Acamprosate and naltrexone effectively reduced the ADE in stock rats. Stress reinstated operant responding for alcohol, and rats trained to associate a cue with ethanol presentation increased responding on the ethanol-associated lever in the absence of ethanol. After repeated deprivations, P rats shifted their preference toward drinking higher concentrations of ethanol, which increased the magnitude and duration of the ADE. Stock rats also shifted their preference toward solutions with higher ethanol concentrations and demonstrated a loss of control after prolonged ethanol drinking and deprivation. Long-lasting alterations in neuronal activity, serotonin-3 receptor function, and dopamine neurotransmission within the mesolimbic system were evident after chronic drinking that followed a prolonged deprivation period. Conclusions: The ADE is a useful model for studying alcohol relapse in both rats and mice. The potential validity of this model is supported by the findings that acamprosate and naltrexone are effective in preventing the ADE in rodents, and both compounds have gained recognition for their therapeutic effects in clinical populations. Genetics, stress, and environmental cues are all important factors that influence alcohol relapse. Long-term alterations in neuronal activity within the mesolimbic system, which possibly involve dopamine and serotonin, may underlie alcohol relapse.

Animal models for studying therapeutic targets and treatments for alcohol use disorder

Environmental enrichment and complementary clinical interventions as therapeutic approaches for alcohol use disorder in animal models and humans

Animal models of compulsion alcohol drinking: Why we love quinine-resistant intake and what we learned from it

Emerging pharmacological targets for alcohol use disorder

A Systematic Review and Meta-analysis on the Transcriptomic Signatures in Alcohol Use Disorder

Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment

Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

Introduction: Approved treatments for alcohol use disorder by regulatory agencies

GABAergic compounds for the treatment of alcohol use disorder

Central nervous system mechanisms in alcohol relapse

Animal models of binge drinking, current challenges to improve face validity

A Model of Ethanol Self-Administration in Head-Fixed Mice

Pre- and postsynaptic signatures in the prelimbic cortex associated with "alcohol use disorder" in the rat

Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

Unlocking the role of dorsal hippocampal α4β2 nicotinic acetylcholine receptors in Ethanol-Induced conditioned place preference in mice

Bulk and Single-cell Transcriptomic Brain Data Identify Overlapping Processes and Cell-types with Human AUD and Mammalian Models of Alcohol Use

β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in Rodents

Novel medications for problematic alcohol use

Human laboratory models of reward in substance use disorder

Standard rodent diets differentially impact alcohol consumption, preference, and gut microbiome diversity